Beta Change co-founder, Pei Yan, recently visited San Diego – and her visit coincided with the American Diabetes Association’s 77th Scientific Sessions (attended by fellow Beta Change co-founder Robert Brooks). Here she shares her top tech takeaways – try saying that ten times fast! – of the world’s biggest diabetes conference.
We checked out Johnson & Johnson’s brand-new OneTouch product: the OneTouch Via. It is a thin, tubeless, on-demand insulin delivery system. There is a trigger mechanism by each side of the patch and each simultaneous click delivers 2 units of insulin. Pretty sleek and no hassle of dangling tubing. The only downside is that it only delivers exactly 2 units of insulin per click, so sorry, no 1 or half units doses!
After clinical trials of the highly anticipated 670G system by Medtronic, the insulin pump is officially in the U.S. market. Users of the 630G system will be first in line for an upgrade. The 670G comes with an algorithm (when used with the Guardian 3 sensor) that detects glucose patterns of the user throughout the day and then automatically suspends and resumes or adjusts basal delivery accordingly. The display interface is quite different when compared to the 630G/ 640G system with its coloured shield display.
Also available at the Medtronic booth was the improved i-port system for MDIs. The i-port Advance system comes with an integrated inserter (similar to their Mio infusion set) which makes inserting the i-port much easier. The product was launched in 2014 (no wonder I find the inserter familiar – we had the chance to trial it at the Singapore children’s diabetes camp two years ago).
OpenAPS refers to Open Artificial Pancreas System, such as Nightscout. It provides a platform for communication and information for anyone with compatible medical devices who is willing to build their own basic artificial pancreas system. It is quite interesting to see the trend of somebody’s blood glucose on the computer’s screen. Not only does it show the most recent trend, but it also shows the trend of the past 72 hours.
Other interesting new technologies showcased at the ADA conference include a new receiver from Dexcom and a soon to be launched device by Omnipod, as reported by diaTribe.
I also had the opportunity to meet with many people whom I have been wanting to meet face to face. On a somewhat somber note, I was invited to join in the informal farewell toast for Diabetes Hands Foundation as they close their operations and are absorbed by Beyond Type 1.
I wished I could have stayed longer to meet more people, but unfortunately I had other travel plans.
Catch up on more tech news and diabetes community updates on Twitter by using the hashtag #2017ADA.
Edited post; republished with permission from Pei Yan’s blog.